FreeHand is a robotic surgical camera controller that aims to make surgeries precise and safer. The company cites data arguing that over 15 million keyhole surgeries are performed annually in which an additional clinician is mostly required to manually hold the camera the surgeon uses to see the operating field. The company asserts that this is not the most optimal way. FreeHand's robotic camera controller aims to solve this issue by providing steady images and precise control, saving time, and improving outcomes. The company has regulatory clearance for sale in the EU, US, and Japan. FreeHand points out that surgical robotics is one of the fastest-growing segments in Medical Technology, projected to reach $91.5 billion by 2025. It aims to become a contender in this segment. FreeHand claims that surgeons have successfully used its robotic controller in more than 15,000 procedures. The company will use the investment to expand the distributor base in Europe, Asia and Latin America, targeting over 12 million procedures annually.
days to go:
Expired
investment:
£1,003,350
Hydro Wind Energy (HWE) is developing technologies to solve global issues of low-cost clean electricity, grid-scale energy storage, and seawater desalination. Its OceanHydro Wind technology harnesses offshore altitude wind using kites, stores the energy subsea and releases it on demand as electrical energy. HWE has also developed SubSea RO Wind technology to desalinate seawater into potable freshwater. The company has developed QuenchSea, which it asserts is the world's only low-cost handheld seawater desalination device. HWE has featured in publications like Wired, Euronews, Business Insider, and Yahoo Finance. It was selected as one of the top 100 start-ups shaping the 4th Industrial Revolution by the World Economic Forum (WEF). HWE will use the investment to fund technology development, product development teams, international expansion, and scale QuenchSea globally.
days to go:
Expired
investment:
£696,260
Trecento Diagnostics, with the help of a molecular testing system complete, they are now ready to launch a patent-pending collection device named HygieCatch®. It is a non-invasive, needle-free examination, in the vet practice providing DNA extraction from urine onsite with a report within 40 minutes of extraction of the sample. The company has identified partners in the UAE and US and is also in early-stage discussions with UK vet practices. Furthermore, for the purpose of commercialisation of HygieCatch & the technology used, alongside addition of new tests including Lyme disease the company is planning to raise its capital.
days to go:
Expired
investment:
£167,910
An innovative solution to the ocean's plastic issues with the use of plasma treatment facilities. Ocean Polymers are utilising technology similar to that of the US Navy, by using a combination of ship and land-based recycling and manufacturing processes. Partnering with QA-UK, the company have developed sea drones to identify plastic waste to aid in cleaning the ocean. This method results in operational savings and a smaller carbon footprint.
days to go:
Expired
investment:
£403,470
Zero Carbon Farms (ZCF) is one of the first Controlled Environment Farms (CEF) that supplies blue-chip customers with local, nutritious and sustainable produce all year round. The company argues that its indoor farm has reduced growing days by up to 50% and increased average yields by 20% compared to conventional farming. ZCF asserts that it is carbon neutral, powered by 100% renewable energy, and is soon to acquire a 'B Corporation' certification in 2021. It aims to become a contender in the micro herbs and indoor salads market in the UK that is worth £624 million per annum. ZCF has supplied 274,863 units of fresh produce in 2019/2020 and is a supplier to Marks and Spencer, Whole Foods, Tesco, and Reynolds Catering Supplies. The company has also entered into R&D partnerships with Cambridge University, Nottingham Trent University, and Alan Turing Institute. It will use the investment to build a second farm on a new site, automate key processes, and invest in further yield-improving technologies.
days to go:
Expired
investment:
£4,301,337
An innovation event that displays the greatest in medical healthcare technologies within exhibitions, conferences and workshops. GIANT Health has over 2000 delegates registered, with 235 speakers and 33 exhibitors whilst being sponsored by 8 global companies. Current revenue streams consist of event ticket sales, partnership packages, stage demos, etc. Events are held across Europe, with international expansion in the next phase.
days to go:
Expired
investment:
£62,770
Lightpoint Medical is a technology company that is a pioneer in developing and marketing precision-guided cancer surgery. Surgeons aren't able to see if the cancerous tissue has been removed in its entirety or not during a surgery. To better this situation, the company has developed an imaging technology based on PET radiopharmaceuticals, more precisely, Cerenkov Luminescence Imaging (CLI), which helps surgeons to detect cancer in a real-time during surgery. The company's first product has received marketing authorisation, i.e., the CE (European Conformity) Mark. A second product, a laparoscopic device for prostate cancer is in development. A non-clinical device has also been released. For its efforts, Lightpoint Medical won the 'Best in Show' Award at the 2014 MedTech Investing Europe Conference. The company aims to utilise the investment to scale its business.
days to go:
Expired
investment:
Withheld
Speeding up access to mental health treatments by using electronic forms and universal communication tools. Thalamos has created a solution for multiple health entities such as the NHS, social services, charities, etc. The company aims to move these entities away from pen and paper, to an easy-to-use online platform, as manual entries are prone to information and data being misplaced, as well as prone to errors.
Thalamos's cloud platform will enable psychiatrists to reduce their clinical and information governance risk, whilst helping to continuously improve their patients' recovery process. The product will be subscription-based from £600 per year, which can be paid monthly and is in-line with other professional services.
days to go:
Expired
investment:
£171,548
Loowatt is delivering safe sanitation and generating energy from waste for sustainable business growth. Loowatt argues that poor sanitation leads to more than £150 billion being lost every year due to health care costs, decreased income and productivity. It aims to change this with its patented toilet. The toilet's waterless flush seals waste hygienically away and is the starting point for Loowatt's unique closed-loop processing system. Loowatt works closely with the local utility partners and ensures that waste is safely collected, treated, and transformed into biogas to generate electricity and heat with nutrients captured for organic fertiliser production. Loowatt has processed 555 tonnes of waste and served more than 250,000 people. The company will use the investment to scale-up manufacturing, complete development of the Loowatt Pro data transmission system, and develop an aftersales monetisation strategy for large international contracts, starting with the City of Manila.
days to go:
Expired
investment:
£1,101,180
Aspira is dedicated to leveraging drones and sustainable coatings for environmental improvement. Their technology directly addresses issues like air pollution, carbon reduction, wind turbine cleaning, and extends material lifespan. Aspira develops drone technology to efficiently apply eco-friendly coatings for a better environment.
days to go:
Expired
investment:
£341,564
